arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Ascend Wellness Holdings, Inc.

AAWH
— Price unavailable
Materials ·Medicinal Chemicals & Botanical Products ·USMedicinal Chemicals & Botanical Products
7 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
59
Health
Fair
Neutral
auto_awesome

Analytical Summary

Ascend Wellness Holdings, Inc. demonstrates solid fundamentals with strength in Return on Common Equity (%). However, watch Profit Margin (%) which shows concerning trends. Consider comparing against peers in the Materials sector before making investment decisions.

Market Cap —
Dividend Yield —
Revenue Growth -10.9% ↘
Op. Margin -3.4% ↘
ROIC -11.1% ↘
FCF / Share $0.06 ↘
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity -6.74
info Valuation on last close.

7-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$500.58M
↓ -10.9% —
Net Income Profit after all expenses
$-118.19M
↓ -39.1% —
Operating Margin Operating profit as % of sales
-3.4%
↓ -503.2% 22th
FCF / Share Free cash flow per share
$0.06
↓ -75.2% —
Long-Term Debt Long-term obligations
$319.52M
↑ +3.7% —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑
21
Returns
100
Financial Health ↓
74
Cash Quality
18

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 7 years · 27 quarters